These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12097414)

  • 1. Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice.
    Carvalho-Pinto CE; García MI; Mellado M; Rodríguez-Frade JM; Martín-Caballero J; Flores J; Martínez-A C; Balomenos D
    J Immunol; 2002 Jul; 169(2):1058-67. PubMed ID: 12097414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
    J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.
    Fan X; Wüthrich RP
    Inflammation; 1997 Feb; 21(1):105-12. PubMed ID: 9179626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice.
    Shimizu S; Nakashima H; Karube K; Ohshima K; Egashira K
    Clin Exp Rheumatol; 2005; 23(2):239-42. PubMed ID: 15895897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
    Haas C; Ryffel B; Le Hir M
    J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
    Front Immunol; 2021; 12():584414. PubMed ID: 33717066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/
    Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.
    Balomenos D; Rumold R; Theofilopoulos AN
    J Clin Invest; 1998 Jan; 101(2):364-71. PubMed ID: 9435308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice.
    Timoshanko JR; Holdsworth SR; Kitching AR; Tipping PG
    J Immunol; 2002 Apr; 168(8):4135-41. PubMed ID: 11937574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.
    Sekine H; Watanabe H; Gilkeson GS
    J Immunol; 2004 Mar; 172(6):3913-21. PubMed ID: 15004199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
    J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.
    Kinoshita K; Tesch G; Schwarting A; Maron R; Sharpe AH; Kelley VR
    J Immunol; 2000 Jun; 164(11):6046-56. PubMed ID: 10820290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.